Research ArticleArticle
Open Access
Clinical Consequences of Delayed Addition of Adalimumab to Methotrexate Therapy Over 5 Years in Patients with Rheumatoid Arthritis
Edward C. Keystone, Arthur Kavanaugh, Michael E. Weinblatt, Kaushik Patra and Aileen L. Pangan
The Journal of Rheumatology February 2011, jrheum.100752; DOI: https://doi.org/10.3899/jrheum.100752
Edward C. Keystone
Arthur Kavanaugh
Michael E. Weinblatt
Kaushik Patra
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Clinical Consequences of Delayed Addition of Adalimumab to Methotrexate Therapy Over 5 Years in Patients with Rheumatoid Arthritis
Edward C. Keystone, Arthur Kavanaugh, Michael E. Weinblatt, Kaushik Patra, Aileen L. Pangan
The Journal of Rheumatology Feb 2011, jrheum.100752; DOI: 10.3899/jrheum.100752
Clinical Consequences of Delayed Addition of Adalimumab to Methotrexate Therapy Over 5 Years in Patients with Rheumatoid Arthritis
Edward C. Keystone, Arthur Kavanaugh, Michael E. Weinblatt, Kaushik Patra, Aileen L. Pangan
The Journal of Rheumatology Feb 2011, jrheum.100752; DOI: 10.3899/jrheum.100752